ADUS icon

Addus HomeCare

109.23 USD
-2.84
2.53%
At close Feb 21, 4:00 PM EST
After hours
109.23
+0.00
0.00%
1 day
-2.53%
5 days
-5.95%
1 month
-19.64%
3 months
-9.61%
6 months
-17.53%
Year to date
-12.10%
1 year
19.46%
5 years
11.28%
10 years
415.72%
 

About: Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Employees: 34,846

0
Funds holding %
of 7,139 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

177% more call options, than puts

Call options by funds: $1.49M | Put options by funds: $539K

46% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 87

1.22% more ownership

Funds ownership: 97.92% [Q3] → 99.14% (+1.22%) [Q4]

4% less capital invested

Capital invested by funds: $2.36B [Q3] → $2.25B (-$102M) [Q4]

4% less funds holding

Funds holding: 306 [Q3] → 294 (-12) [Q4]

13% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 39

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$150
37%
upside
Avg. target
$150
37%
upside
High target
$150
37%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Oppenheimer
Ari Wald
0% 1-year accuracy
0 / 1 met price target
37%upside
$150
Outperform
Maintained
24 Jan 2025
JMP Securities
Constantine Davides
40% 1-year accuracy
12 / 30 met price target
37%upside
$150
Market Outperform
Initiated
16 Dec 2024

Financial journalist opinion

Based on 8 articles about ADUS published over the past 30 days

Positive
Zacks Investment Research
1 day ago
3 Reasons Why Growth Investors Shouldn't Overlook Addus HomeCare (ADUS)
Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Why Growth Investors Shouldn't Overlook Addus HomeCare (ADUS)
Positive
Zacks Investment Research
1 day ago
Should Value Investors Buy Addus HomeCare (ADUS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Addus HomeCare (ADUS) Stock?
Positive
Zacks Investment Research
2 days ago
Pick These 4 Stocks With Impressive Interest Coverage Ratios
DECK, BOOT, ADUS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Pick These 4 Stocks With Impressive Interest Coverage Ratios
Positive
Zacks Investment Research
2 days ago
Ahead of Addus HomeCare (ADUS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Addus HomeCare (ADUS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Ahead of Addus HomeCare (ADUS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Positive
Zacks Investment Research
1 week ago
ADUS vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Chemed (CHE). But which of these two stocks is more attractive to value investors?
ADUS vs. CHE: Which Stock Is the Better Value Option?
Neutral
Business Wire
1 week ago
Addus HomeCare Announces Fourth Quarter and Year-end 2024 Earnings Release and Conference Call
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2024, on Monday, February 24, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, February 25, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bic.
Addus HomeCare Announces Fourth Quarter and Year-end 2024 Earnings Release and Conference Call
Neutral
Zacks Investment Research
3 weeks ago
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?
ADUS or USPH: Which Is the Better Value Stock Right Now?
Negative
Zacks Investment Research
3 weeks ago
Are Medical Stocks Lagging Addus HomeCare (ADUS) This Year?
Here is how Addus HomeCare (ADUS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Addus HomeCare (ADUS) This Year?
Neutral
Zacks Investment Research
1 month ago
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
Positive
Zacks Investment Research
1 month ago
4 Stocks to Monitor in a Dynamic Outpatient Home Health Industry
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, OPCH and ADUS are well-poised to gain.
4 Stocks to Monitor in a Dynamic Outpatient Home Health Industry
Charts implemented using Lightweight Charts™